Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT01947426

Effect of Mother DHA Supplementation on Term Newborn.

Effect of Maternal Supplementation With DHA During Pregnancy and Lactation on the Development of the Term Newborn

Sponsor: Puleva Biotech

Conditions Infant Development Inflammation Oxidative Stress

Interventions Control (milk without DHA) DHA Supplementation

Updated 5 times since 2017 Last updated: Sep 17, 2013 Started: Apr 30, 2008 Primary completion: Apr 30, 2010 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Infant Development and Inflammation and is currently completed. Puleva Biotech leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2_PHASE3

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Puleva Biotech
Universidad de Granada

Data source: Universidad de Granada

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Granada, Spain